CoChat

γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct

Open access
Ran, Yong, Hossain, Fokhrul, Pannuti, Antonio, Lessard, Christian B, Ladd, Gabriela Z, Jung, Joo In, Minter, Lisa M, Osborne, Barbara A, Miele, Lucio, Golde, Todd E · 2017 · EMBO Molecular Medicine
Cited by 128

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

γ‐Secretase inhibitors ( GSI s) are being actively repurposed as cancer therapeutics based on the premise that inhibition of NOTCH 1 signaling in select cancers is therapeutic. Using novel assays to probe effects of GSI s against a broader panel of substrates, we demonstrate that clinical GSI s are pharmacologically distinct. GSI s show differential profiles of inhibition of the various NOTCH substrates, with some enhancing cleavage of other NOTCH substrates at concentrations where NOTCH 1 cleavage is inhibited. Several GSI s are also potent inhibitors of select signal peptide peptidase ( SPP / SPPL ) family members. Extending these findings to mammosphere inhibition assays in triple‐negative breast cancer lines, we establish that these GSI s have different functional effects. We also demonstrate that the processive γ‐secretase cleavage pattern established for amyloid precursor protein ( APP ) occurs in multiple substrates and that potentiation of γ‐secretase cleavage is attributable to a direct action of low concentrations of GSI s on γ‐secretase. Such data definitively demonstrate that the clinical GSI s are not biological equivalents, and provide an important framework to evaluate results from ongoing and completed human trials with these compounds.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/emmm.201607265

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 128

Metadata

Authors
Ran, Y., Hossain, F., Pannuti, A., Lessard, C. B., Ladd, G. Z., Jung, J. I., Minter, L. M., Osborne, B. A., Miele, L., & Golde, T. E.
Venue
EMBO Molecular Medicine
Published
2017-05-24
Volume
9
Issue
7
Pages
950-966
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2618466363
Cited by
128
References
10
FWCI
10.13
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.